The Joe Rogan Experience #2376 - Brigham Buhler
383 snips
Sep 9, 2025 Brigham Buhler, founder of Ways2Well, dives deep into the world of functional and regenerative medicine. He discusses the alarming profit motives of pharmaceutical companies and the need for transparency in healthcare. The conversation also covers the controversial role of peptides versus traditional medicine, the challenges posed by FDA regulations, and the growing interest in psychedelic treatments for mental health. Buhler’s insights into preventative care and patient empowerment add a refreshing perspective to the ongoing healthcare debate.
AI Snips
Chapters
Books
Transcript
Episode notes
Industry Capture Shapes Drug Policy
- Big Pharma and regulators are deeply entangled, shaping access and pricing of therapies.
- Joe Rogan and Brigham Buhler argue industry capture drives policy that favors profit over patient choice.
Friendly FDA Meeting, Then 'They'll Smile'
- Joe described his meeting with FDA officials who were friendly but later told him, "They're going to smile."
- That contact warned Rogan the agency would outwardly listen then push industry-favoring rules.
Microdose And Stack GLP-1s To Preserve Muscle
- Start patients on microdoses and personalize titration to reduce muscle loss and side effects from GLP-1 therapies.
- Combine GLP-1s with agents like IGF-1 LR3 to preserve lean mass and bone while losing fat.
